Published in Clin Rheumatol on May 09, 2010
Fibroblasts in fibrosis: novel roles and mediators. Front Pharmacol (2014) 1.47
Vitamin D in systemic sclerosis. Clin Rheumatol (2010) 1.44
Relationship between Body Mass Composition, Bone Mineral Density, Skin Fibrosis and 25(OH) Vitamin D Serum Levels in Systemic Sclerosis. PLoS One (2015) 1.44
Does vitamin D affect risk of developing autoimmune disease?: a systematic review. Semin Arthritis Rheum (2010) 1.39
Pathogenesis of Systemic Sclerosis. Front Immunol (2015) 0.89
Vitamin D and its emerging role in immunopathology. Clin Rheumatol (2011) 0.89
Bone mineral density, bone turnover markers and fractures in patients with systemic sclerosis: a case control study. PLoS One (2013) 0.88
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature. Clin Rheumatol (2017) 0.86
Clinical, biochemical, and radiological characterization of the calcinosis in a cohort of Mexican patients with systemic sclerosis. Clin Rheumatol (2016) 0.83
Bone density in Moroccan women with systemic scleroderma and its relationships with disease-related parameters and vitamin D status. Rheumatol Int (2011) 0.83
Systemic sclerosis: current concepts in pathogenesis and therapeutic aspects of dermatological manifestations. Indian J Dermatol (2013) 0.81
The role of vitamin D supplementation in patients with rheumatic diseases. Nat Rev Rheumatol (2013) 0.78
A vitamin D analog inhibits Th2 cytokine- and TGFβ -induced periostin production in fibroblasts: a potential role for vitamin D in skin sclerosis. Dermatoendocrinol (2015) 0.78
Circulating biomarkers of interstitial lung disease in systemic sclerosis. Int J Rheumatol (2012) 0.77
Vitamin D deficiency in systemic sclerosis: a possible role of subclinical liver fibrosis? Retrospective analysis from an Italian cohort. Clin Rheumatol (2017) 0.76
Seasonal variations in serum levels of 25-hydroxyvitamin D in patients with systemic sclerosis. Clin Rheumatol (2011) 0.76
Early life environment and developmental immunotoxicity in inflammatory dysfunction and disease. Toxicol Environ Chem (2015) 0.76
Low vitamin D status in systemic sclerosis and the impact on disease phenotype. Eur J Rheumatol (2016) 0.76
Skin Involvement and Pulmonary Hypertension Are Associated with Vitamin D Insufficiency in Scleroderma. Int J Mol Sci (2016) 0.75
Vitamin D and autoimmune rheumatic diseases. Clin Rheumatol (2011) 0.75
Endothelin-1, α-Klotho, 25(OH) Vit D levels and severity of disease in scleroderma patients. Rheumatol Int (2017) 0.75
Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum (1980) 21.86
Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol (1988) 16.45
Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am J Pathol (2005) 5.88
Noncalcemic actions of vitamin D receptor ligands. Endocr Rev (2005) 3.34
Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys (2000) 2.65
Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol (2000) 2.61
European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis (2001) 2.49
Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev (2005) 2.25
Vitamin D deficiency and insufficiency in 2 independent cohorts of patients with systemic sclerosis. J Rheumatol (2009) 2.19
1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest (1991) 2.17
Assessment of disease severity and prognosis. Clin Exp Rheumatol (2003) 1.86
Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells. J Endocrinol (2008) 1.72
Vitamin D, parathyroid hormone, and acroosteolysis in systemic sclerosis. J Rheumatol (2008) 1.58
Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology (2009) 1.45
Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors. Osteoporos Int (2003) 1.36
Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population. Br J Rheumatol (1996) 1.27
Vitamin D inhibition of pro-fibrotic effects of transforming growth factor beta1 in lung fibroblasts and epithelial cells. J Steroid Biochem Mol Biol (2009) 1.27
Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann N Y Acad Sci (2007) 1.26
The complex role of vitamin D in autoimmune diseases. Scand J Immunol (2008) 1.25
25-hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus. Arthritis Rheum (2009) 1.20
Vitamin D deficiency in undifferentiated connective tissue disease. Arthritis Res Ther (2008) 1.19
Hypovitaminosis D is associated with greater body mass index and disease activity in pediatric systemic lupus erythematosus. J Pediatr (2009) 1.12
Assessment of lung involvement. Clin Exp Rheumatol (2003) 0.95
Assessment of skin, joint, tendon and muscle involvement. Clin Exp Rheumatol (2003) 0.92
Vitamin D-mediated gene regulation in phenotypically defined human B cell subpopulations. Endocrinology (2000) 0.89
Circulating osteoprotegerin and soluble RANK ligand in systemic sclerosis. J Rheumatol (2008) 0.80
Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed? Eur Urol (2010) 2.82
Prognostic impact of the 2009 UICC/AJCC TNM staging system for renal cell carcinoma with venous extension. Eur Urol (2010) 1.99
Association of polymorphisms in the IL1B and IL2 genes with susceptibility and severity of systemic sclerosis. J Rheumatol (2007) 1.87
Is renal warm ischemia over 30 minutes during laparoscopic partial nephrectomy possible? One-year results of a prospective study. Eur Urol (2007) 1.83
Reproductive factors and the risk of scleroderma: an Italian case-control study. Arthritis Rheum (2002) 1.67
Laparoscopic versus open partial nephrectomy: analysis of the current literature. Eur Urol (2008) 1.66
The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful? Clin Chem Lab Med (2011) 1.65
Intraoperative radiotherapy during radical prostatectomy for locally advanced prostate cancer: technical and dosimetric aspects. Int J Radiat Oncol Biol Phys (2009) 1.60
Urological laparoendoscopic single site surgery: multi-institutional analysis of risk factors for conversion and postoperative complications. J Urol (2012) 1.50
Assessment of risk factors for complications of laparoscopic partial nephrectomy. Eur Urol (2007) 1.44
Soluble TNF-like cytokine (TL1A) production by immune complexes stimulated monocytes in rheumatoid arthritis. J Immunol (2007) 1.44
Comparative effect of tacrolimus 0.1% ointment and clobetasol 0.05% ointment in patients with oral lichen planus. J Clin Periodontol (2008) 1.43
Epigenetic control of 11 beta-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension. Atherosclerosis (2008) 1.26
The utility of serum human epididymis protein 4 (HE4) in patients with a pelvic mass. J Clin Lab Anal (2009) 1.20
Simple enucleation is equivalent to traditional partial nephrectomy for renal cell carcinoma: results of a nonrandomized, retrospective, comparative study. J Urol (2011) 1.19
Antibodies against cyclic citrullinated peptides in patients affected by rheumatoid arthritis before and after infliximab treatment. Rheumatol Int (2005) 1.06
Longterm retention of tumor necrosis factor-α inhibitor therapy in a large italian cohort of patients with rheumatoid arthritis from the GISEA registry: an appraisal of predictors. J Rheumatol (2012) 1.02
Diagnostic accuracy and clinical impact of imaging-guided needle biopsy of renal masses. Retrospective analysis on 150 cases. Eur Radiol (2010) 1.02
The early psoriatic arthritis screening questionnaire: a simple and fast method for the identification of arthritis in patients with psoriasis. Rheumatology (Oxford) (2012) 1.02
Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study. Ann Rheum Dis (2011) 1.00
Psoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than those with normal nails. Ann Rheum Dis (2011) 0.98
Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjoegren syndrome or hepatitis C virus infection. Br J Haematol (2004) 0.97
The role of resistin in colorectal cancer. Clin Chim Acta (2012) 0.95
Open versus laparoscopic partial nephrectomy for clinical T1a renal masses: a matched-pair comparison of 280 patients with TRIFECTA outcomes (RECORd Project). World J Urol (2013) 0.94
Anti-TNFalpha therapy in rheumatoid arthritis and autoimmunity. Rheumatol Int (2004) 0.93
Relationship between matrix metalloproteinases/tissue inhibitors of matrix metalloproteinases systems and autoantibody patterns in systemic sclerosis. Clin Biochem (2007) 0.93
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry. Autoimmun Rev (2012) 0.92
Biopsy and treatment decisions in the initial management of prostate cancer and the role of PCA3; a systematic analysis of expert opinion. World J Urol (2011) 0.90
Coexistence of systemic sclerosis with other autoimmune diseases. Rheumatol Int (2006) 0.89
Evidence for caveolin-1 as a new susceptibility gene regulating tissue fibrosis in systemic sclerosis. Ann Rheum Dis (2012) 0.88
Contemporary urologic minilaparoscopy: indications, techniques, and surgical outcomes in a multi-institutional European cohort. J Endourol (2014) 0.88
Expression of CD154 on renal cell carcinomas and effect on cell proliferation, motility and platelet-activating factor synthesis. Int J Cancer (2002) 0.87
Robot-assisted sacrocolpopexy for pelvic organ prolapse: surgical technique and outcomes at a single high-volume institution. Eur Urol (2013) 0.87
The co-occurrence of Hashimoto thyroiditis in primary Sjogren's syndrome defines a subset of patients with milder clinical phenotype. Rheumatol Int (2012) 0.87
The diagnostic and therapeutic challenge of early psoriatic arthritis. Dermatology (2010) 0.87
Biomarkers of good EULAR response to the B cell depletion therapy in all seropositive rheumatoid arthritis patients: clues for the pathogenesis. PLoS One (2012) 0.86
Preliminary evidence that subclinical enthesopathy may predict psoriatic arthritis in patients with psoriasis. J Rheumatol (2011) 0.86
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study. Ann Rheum Dis (2013) 0.86
A score of risk factors associated with ischemic digital ulcers in patients affected by systemic sclerosis treated with iloprost. Clin Rheumatol (2009) 0.86
Severe vascular complications in patients affected by systemic sclerosis cyclically treated with iloprost. Rheumatol Int (2011) 0.86
Proteome analysis of biological fluids from autoimmune-rheumatological disorders. Proteomics Clin Appl (2011) 0.85
Evaluation of cardiac laboratory markers in patients with systemic sclerosis. Clin Biochem (2006) 0.85
A case-control study of occupational exposures and systemic sclerosis. Int Arch Occup Environ Health (2003) 0.84
Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study. Medicine (Baltimore) (2015) 0.83
The link between enthesitis and arthritis in psoriatic arthritis: a switch to a vascular phenotype at insertions may play a role in arthritis development. Ann Rheum Dis (2012) 0.82
Cyclophosphamide treatment improves microvessel damage in systemic sclerosis. Clin Rheumatol (2008) 0.82
Relationship between body composition and both cardiovascular risk factors and lung function in systemic sclerosis. Clin Rheumatol (2013) 0.82
A study on thrombophilic factors in Italian Behcet's patients. Joint Bone Spine (2010) 0.82
Anti-TNFalpha blockers, autoantibodies and autoimmune diseases. Joint Bone Spine (2009) 0.81
Pancreatic granulomatous necrotizing vasculitis: a case report and review of the literature. Rheumatol Int (2007) 0.81
What is the contemporary role of radiofrequency ablation in the management of small renal masses? Are small lesions the radiologist's tumors? Eur Urol (2012) 0.81
Preliminary evidence for cell membrane amelioration in children with cystic fibrosis by 5-MTHF and vitamin B12 supplementation: a single arm trial. PLoS One (2009) 0.81
Clinical associations of anti-CENP-B and anti-Scl70 antibody levels measured by multiplexed fluorescent microsphere immunoassay in systemic sclerosis. Rheumatol Int (2009) 0.81
Transmesenteric approach for left transperitoneal renal surgery: technique and experience. J Laparoendosc Adv Surg Tech A (2012) 0.80
External validation of the preoperative Karakiewicz nomogram in a large multicentre series of patients with renal cell carcinoma. World J Urol (2012) 0.80
Homocysteine plasma concentration is related to severity of lung impairment in scleroderma. J Rheumatol (2003) 0.80
Does cyclically iloprost infusion prevent severe isolated pulmonary hypertension in systemic sclerosis? Preliminary results. Rheumatol Int (2006) 0.80
Comparative proteomic analysis of serum from patients with systemic sclerosis and sclerodermatous GVHD. Evidence of defective function of factor H. PLoS One (2010) 0.80
Radical prostatectomy and intraoperative radiation therapy in high-risk prostate cancer. Adv Urol (2012) 0.80
Transperitoneal left laparoscopic pyeloplasty with transmesocolic access to the pelvi-ureteric junction: technique description and results with a minimum follow-up of 1 year. BJU Int (2007) 0.80
Lipoprotein[a] and the lipid profile in patients with systemic sclerosis. Clin Chim Acta (2005) 0.80
Psoriasis onset during infliximab treatment: description of two cases. Rheumatol Int (2006) 0.80
Hydroxychloroquine-induced DRESS syndrome. Clin Rheumatol (2007) 0.80
Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study. Arthritis Rheum (2011) 0.80
The TTTT B lymphocyte stimulator promoter haplotype is associated with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to tumor necrosis factor blockers. Arthritis Rheum (2013) 0.79